Immunome, Inc. (IMNM)
NASDAQ: IMNM · IEX Real-Time Price · USD
11.70
-0.50 (-4.10%)
At close: Jul 2, 2024, 4:00 PM
11.96
+0.26 (2.22%)
After-hours: Jul 2, 2024, 6:27 PM EDT
Immunome Analyst Ratings
Total Analysts
4
Consensus Rating
Strong Buy
Price Target
$29.75
Upside
+154.27%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Initiates $27 | Buy | Initiates | $27 | +130.77% | May 31, 2024 |
| JP Morgan | JP Morgan | Buy Initiates $24 | Buy | Initiates | $24 | +105.13% | Apr 30, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $35 | Strong Buy | Initiates | $35 | +199.15% | Apr 15, 2024 |
| Wedbush | Wedbush | Buy Maintains $27 → $33 | Buy | Maintains | $27 → $33 | +182.05% | Apr 1, 2024 |
| Wedbush | Wedbush | Buy Maintains $12 → $19 | Buy | Maintains | $12 → $19 | +62.39% | Jan 23, 2024 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +2.56% | Dec 19, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $8 | Buy | Reiterates | $8 | -31.62% | Mar 20, 2023 |
| Chardan Capital | Chardan Capital | Strong Buy Maintains $9 → $8 | Strong Buy | Maintains | $9 → $8 | -31.62% | Mar 17, 2023 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Oct 29, 2021 |
| Chardan Capital | Chardan Capital | Strong Buy Initiates n/a | Strong Buy | Initiates | n/a | n/a | Oct 27, 2020 |